Corrigendum to ‘Nafamostat protects against early brain injury after subarachnoid hemorrhage in mice’ [Journal of Pharmacological Sciences 148 (2022) 65–72]

• Hirofumi Matsubara,
• Takahiko Imai,
• Shohei Tsuji,
• Natsumi Oka,
• Yusuke Egashira,
• Yukiko Enomoto,
• Noriyuki Nakayama,
• Shinsuke Nakamura,
• Masamitsu Shimazawa,
• Toru Iwama,
• Hideaki Hara

Affiliations

Hirofumi Matsubara

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan

Takahiko Imai

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Shohei Tsuji

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Natsumi Oka

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Yusuke Egashira

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan

Yukiko Enomoto

Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan

Noriyuki Nakayama

Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan

Shinsuke Nakamura

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Masamitsu Shimazawa

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Toru Iwama

Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan

Hideaki Hara

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Corresponding author. Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4, Daigaku-nishi, Gifu, Japan. Tel.: +81 58 230 8126.